Parenchymal and airway diseases caused by asbestos.

Abstract

PURPOSE OF REVIEW:

The extensive industrial use of asbestos for many decades has been linked to development of benign and malignant pleuropulmonary disease. This review summarizes newer evidence and ongoing controversies that exist in the literature regarding asbestos-related parenchymal and airway diseases.

RECENT FINDINGS:

Asbestosis represents a significant respiratory problem despite the improvement in the workplace hygiene and a decrease in use of asbestos. The management of asbestosis remains challenging as currently there is no specific treatment. The role of asbestos exposure alone as a cause of chronic airway obstruction remains uncertain. The relationship between lung cancer and asbestos exposure alone and in combination with smoking has also been investigated. The benefit of screening for asbestos-related pleuropulmonary disease remains uncertain as does the use of computed tomography scanning for the purpose of screening.

SUMMARY:

Future studies will help clarify the clinical issues and shape screening strategies for asbestos-exposed individuals.

• Authors: Andreea L Antonescu-Turcu, Ralph M Schapira
• Journal: Current opinion in pulmonary medicine (Curr Opin Pulm Med) Vol. 16 Issue 2 Pg. 155-61 (Mar 2010) ISSN: 1531-6971 [Electronic] United States
• PMID: 20104177 (Publication Type: Journal Article, Review)

Chemical References

• Asbestos

Topics

• Asbestos (adverse effects)
• Asbestosis (diagnostic imaging, etiology)
• Humans
• Lung Diseases (chemically induced, diagnostic imaging)
• Lung Diseases, Obstructive (chemically induced, diagnostic imaging)
• Lung Neoplasms (chemically induced, diagnostic imaging)
• Mesothelioma (chemically induced, diagnostic imaging)
• Tomography, X-Ray Computed